Fractyl Health (GUTS) Return on Equity (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Return on Equity data on file, last reported at 0.06% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 1.0% year-over-year to 0.06%; the trailing twelve-month figure through Mar 2026 stood at 0.06% (down 1.0% YoY), and the FY2025 full-year result was 0.05%, down 6.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.06%, up from 0.3% in the prior quarter.
• Across five years, Return on Equity topped out at 0.16% in Q2 2025 and bottomed at 0.3% in Q4 2025.
• A 4-year average of 0.02% and a median of 0.01% in 2024 frame the typical range for Return on Equity.
• Peak annual rise in Return on Equity reached 17 bps in 2025, while the deepest fall reached 28 bps in 2025.
• Tracing GUTS's Return on Equity over 4 years: stood at 0.0% in 2023, then plunged by 1548 bps to 0.02% in 2024, then tumbled by 1237 bps to 0.3% in 2025, then surged by 80 bps to 0.06% in 2026.
• According to Business Quant data, Return on Equity over the past three periods registered 0.06%, 0.3%, and 0.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison